Page last updated: 2024-08-23

paroxetine and Insulin Resistance

paroxetine has been researched along with Insulin Resistance in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boura-Halfon, S; Gurevitch, D; Isaac, R; Levkovitz, Y; Shainskaya, A; Zick, Y1
Deuschle, M; Gilles, M; Henn, FA; Heuser, I; Kopf, D; Lederbogen, F; Lehnert, H; Luley, CW; Ritter, S; Weber-Hamann, B; Westphal, S1
Deuschle, M; Gilles, M; Heuser, I; Lederbogen, F; Weber-Hamann, B1
Ben-Shushan, G; Gil-Ad, I; Hershkovitz, A; Isaac, R; Levkovitz, Y; Ronen, D; Shvartsman, D; Weizman, A; Zick, Y1

Trials

1 trial(s) available for paroxetine and Insulin Resistance

ArticleYear
Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:12

    Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Hypoglycemic Agents; Hypothalamo-Hypophyseal System; Insulin; Insulin Resistance; Male; Middle Aged; Paroxetine; Pituitary-Adrenal System; Risk Factors; Saliva

2006

Other Studies

3 other study(ies) available for paroxetine and Insulin Resistance

ArticleYear
Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.
    The Journal of biological chemistry, 2013, Feb-22, Volume: 288, Issue:8

    Topics: Animals; Apoptosis; Cell Death; Cell Line; Diabetes Mellitus; Fluoxetine; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction; Unfolded Protein Response

2013
Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Blood Glucose; Body Mass Index; Cholesterol; Circadian Rhythm; Coronary Disease; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin Resistance; Lipids; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Obesity; Paroxetine; Pituitary-Adrenal System; Risk Factors; Triglycerides

2004
Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases.
    Molecular and cellular neurosciences, 2007, Volume: 36, Issue:3

    Topics: Animals; Cell Line, Tumor; Diabetes Mellitus; Enzyme Activation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Metabolic Syndrome; Paroxetine; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Selective Serotonin Reuptake Inhibitors; Serine; Sertraline; Signal Transduction

2007